Tiotropium In Exercise

PHASE4CompletedINTERVENTIONAL
Enrollment

519

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

June 30, 2010

Conditions
Pulmonary Disease, Chronic ObstructiveExercise
Interventions
DRUG

tiotropium 18 mcg

Oral inhalation once daily of 18mcg tiotropium via handihaler

DRUG

Placebo

Oral inhalation of once-daily placebo matching tiotropium via handihaler

Trial Locations (62)

Unknown

205.368.01023 Boehringer Ingelheim Investigational Site, Jasper

205.368.01022 Boehringer Ingelheim Investigational Site, Phoenix

205.368.01003 Boehringer Ingelheim Investigational Site, Los Angeles

205.368.01008 Boehringer Ingelheim Investigational Site, Fort Collins

205.368.01017 Boehringer Ingelheim Investigational Site, Hartford

205.368.01028 Boehringer Ingelheim Investigational Site, Waterbury

205.368.01004 Boehringer Ingelheim Investigational Site, Bay Pines

205.368.01013 Boehringer Ingelheim Investigational Site, North Miami Beach

205.368.01025 Boehringer Ingelheim Investigational Site, Hazard

205.368.01029 Boehringer Ingelheim Investigational Site, Biddeford

205.368.01016 Boehringer Ingelheim Investigational Site, Baltimore

205.368.01002 Boehringer Ingelheim Investigational Site, Boston

205.368.01021 Boehringer Ingelheim Investigational Site, Kansas City

205.368.01014 Boehringer Ingelheim Investigational Site, Albany

205.368.01030 Boehringer Ingelheim Investigational Site, Tulsa

205.368.01018 Boehringer Ingelheim Investigational Site, Charleston

205.368.01027 Boehringer Ingelheim Investigational Site, Gaffney

205.368.01019 Boehringer Ingelheim Investigational Site, Greenville

205.368.01020 Boehringer Ingelheim Investigational Site, Spartanburg

205.368.01024 Boehringer Ingelheim Investigational Site, Union

205.368.01015 Boehringer Ingelheim Investigational Site, Dallas

205.368.54001 Boehringer Ingelheim Investigational Site, Rosario

205.368.54002 Boehringer Ingelheim Investigational Site, Vicente López

205.368.55003 Boehringer Ingelheim Investigational Site, Goiânia

205.368.55004 Boehringer Ingelheim Investigational Site, Porto Alegre - RS

205.368.55002 Boehringer Ingelheim Investigational Site, São Paulo

205.368.07006 Boehringer Ingelheim Investigational Site, Vancouver

205.368.07001 Boehringer Ingelheim Investigational Site, Winnipeg

205.368.07003 Boehringer Ingelheim Investigational Site, Winnipeg

205.368.07004 Boehringer Ingelheim Investigational Site, Hamilton

205.368.07005 Boehringer Ingelheim Investigational Site, Hamilton

205.368.07008 Boehringer Ingelheim Investigational Site, Montreal

205.368.49005 Boehringer Ingelheim Investigational Site, Berlin

205.368.49003 Boehringer Ingelheim Investigational Site, Cologne

205.368.49004 Boehringer Ingelheim Investigational Site, Freiburg/Breisgau

205.368.49006 Boehringer Ingelheim Investigational Site, Münster

205.368.49002 Boehringer Ingelheim Investigational Site, Schmallenberg

205.368.49001 Boehringer Ingelheim Investigational Site, Tübingen

205.368.39006 Boehringer Ingelheim Investigational Site, Ferrara

205.368.39004 Boehringer Ingelheim Investigational Site, Milan

205.368.39002 Boehringer Ingelheim Investigational Site, Parma

205.368.39001 Boehringer Ingelheim Investigational Site, Pisa

205.368.35103 Boehringer Ingelheim Investigational Site, Coimbra

205.368.35102 Boehringer Ingelheim Investigational Site, Matosinhos Municipality

205.368.70001 Boehringer Ingelheim Investigational Site, Moscow

205.368.70004 Boehringer Ingelheim Investigational Site, Moscow

205.368.70005 Boehringer Ingelheim Investigational Site, Moscow

205.368.70006 Boehringer Ingelheim Investigational Site, Moscow

205.368.70007 Boehringer Ingelheim Investigational Site, Saint Petersburg

205.368.34005 Hospital Germans Trias i Pujol, Badalona (Barcelona)

205.368.34002 Hospital de Cruces, Barakaldo (Bilbao)

205.368.34001 Hospital Clinic i Provincial de Barcelona, Barcelona

205.368.34003 Hospital Gregorio Maranon, Madrid

205.368.34004 Hospital Universitario Vírgen del Rocío, Seville

205.368.34006 Boehringer Ingelheim Investigational Site, Seville

205.368.88604 Boehringer Ingelheim Investigational Site, Keelung

205.368.88602 Boehringer Ingelheim Investigational Site, Taichung

205.368.88603 Boehringer Ingelheim Investigational Site, Taipei

205.368.88601 Chang Gung Memorial Hosp-Linkou, Taoyuan District

205.368.38003 Boehringer Ingelheim Investigational Site, Dnyepropyetrovsk

205.368.38001 Boehringer Ingelheim Investigational Site, Kiev

205.368.38002 Boehringer Ingelheim Investigational Site, Kiev

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY

NCT00525512 - Tiotropium In Exercise | Biotech Hunter | Biotech Hunter